Sex matters: Systemic complement activity of female C57BL/6J and BALB/cJ mice is limited by serum terminal pathway components

Juha Kotimaa; Ngaisah Klar-Mohammad; Faikah Gueler; Geurt Schilders; Aswin Jansen; Helma Rutjes; Mohamed R. Daha; Cees van Kooten

doi:10.1016/j.molimm.2016.06.004

Sex matters: Systemic complement activity of female C57BL/6J and BALB/cJ mice is limited by serum terminal pathway components

Juha Kotimaa, Ngaisah Klar-Mohammad, Faikah Gueler, Geurt Schilders, Aswin Jansen, Helma Rutjes, Mohamed R. Daha, Cees van Kooten

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	Molecular Immunology
Volume	76
Issue number	13-21
Pages (from-to)	13-21
Number of pages	9
ISSN	0161-5890
DOIs	https://doi.org/10.1016/j.molimm.2016.06.004
Publication status	Published - Aug 2016
Externally published	Yes
MoE publication type	A1 Journal article-refereed

Access to Document

10.1016/j.molimm.2016.06.004

Cite this

@article{b7b397cb9d7a43b6974531d3cb5f79fa,

title = "Sex matters: Systemic complement activity of female C57BL/6J and BALB/cJ mice is limited by serum terminal pathway components",

author = "Juha Kotimaa and Ngaisah Klar-Mohammad and Faikah Gueler and Geurt Schilders and Aswin Jansen and Helma Rutjes and Daha, {Mohamed R.} and {van Kooten}, Cees",

year = "2016",

month = aug,

doi = "10.1016/j.molimm.2016.06.004",

language = "English",

volume = "76",

pages = "13--21",

journal = "Molecular Immunology",

issn = "0161-5890",

publisher = "Elsevier Scientific Publ. Co",

number = "13-21",

}

TY - JOUR

T1 - Sex matters

T2 - Systemic complement activity of female C57BL/6J and BALB/cJ mice is limited by serum terminal pathway components

AU - Kotimaa, Juha

AU - Klar-Mohammad, Ngaisah

AU - Gueler, Faikah

AU - Schilders, Geurt

AU - Jansen, Aswin

AU - Rutjes, Helma

AU - Daha, Mohamed R.

AU - van Kooten, Cees

PY - 2016/8

Y1 - 2016/8

U2 - 10.1016/j.molimm.2016.06.004

DO - 10.1016/j.molimm.2016.06.004

M3 - Article

SN - 0161-5890

VL - 76

SP - 13

EP - 21

JO - Molecular Immunology

JF - Molecular Immunology

IS - 13-21

ER -